74 related articles for article (PubMed ID: 19948974)
1. Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis.
Onoue K; Uemura S; Takeda Y; Somekawa S; Iwama H; Imagawa K; Nishida T; Morikawa Y; Takemoto Y; Asai O; Soeda T; Okayama S; Ishigami K; Nakatani K; Kawata H; Horii M; Nakajima T; Akai Y; Iwano M; Saito Y
Circulation; 2009 Dec; 120(24):2470-7. PubMed ID: 19948974
[TBL] [Abstract][Full Text] [Related]
2. Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease.
Matsui M; Takeda Y; Uemura S; Matsumoto T; Seno A; Onoue K; Tsushima H; Morimoto K; Soeda T; Okayama S; Somekawa S; Samejima K; Kawata H; Kawakami R; Nakatani K; Iwano M; Saito Y
Kidney Int; 2014 Feb; 85(2):393-403. PubMed ID: 24048373
[TBL] [Abstract][Full Text] [Related]
3. Suppressed Production of Soluble Fms-Like Tyrosine Kinase-1 Contributes to Myocardial Remodeling and Heart Failure.
Seno A; Takeda Y; Matsui M; Okuda A; Nakano T; Nakada Y; Kumazawa T; Nakagawa H; Nishida T; Onoue K; Somekawa S; Watanabe M; Kawata H; Kawakami R; Okura H; Uemura S; Saito Y
Hypertension; 2016 Sep; 68(3):678-87. PubMed ID: 27480835
[TBL] [Abstract][Full Text] [Related]
4. Elevated Soluble Fms-Like Tyrosine Kinase-1 and Placental-Like Growth Factor Levels Are Associated With Development and Mortality Risk in Heart Failure.
Hammadah M; Georgiopoulou VV; Kalogeropoulos AP; Weber M; Wang X; Samara MA; Wu Y; Butler J; Tang WH
Circ Heart Fail; 2016 Jan; 9(1):e002115. PubMed ID: 26699385
[TBL] [Abstract][Full Text] [Related]
5. An elevated ratio of placental growth factor to soluble fms-like tyrosine kinase-1 predicts adverse outcomes in patients with stable coronary artery disease.
Matsumoto T; Uemura S; Takeda Y; Matsui M; Okada S; Nishida T; Soeda T; Okayama S; Somekawa S; Ishigami K; Onoue K; Kawata H; Kawakami R; Horii M; Saito Y
Intern Med; 2013; 52(10):1019-27. PubMed ID: 23676585
[TBL] [Abstract][Full Text] [Related]
6. The role of the PlGF/Flt-1 signaling pathway in the cardiorenal connection.
Saito Y
J Mol Cell Cardiol; 2021 Feb; 151():106-112. PubMed ID: 33045252
[TBL] [Abstract][Full Text] [Related]
7. Letter by Di Marco and Brand regarding article, "Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis".
Di Marco GS; Brand M
Circulation; 2010 Aug; 122(5):e416; athor reply e417. PubMed ID: 20679579
[No Abstract] [Full Text] [Related]
8. Increased soluble fms-like tyrosine kinase 1 after ischemia reperfusion contributes to adverse clinical outcomes following kidney transplantation.
Wewers TM; Mayer AB; Pfleiderer A; Beul K; Schmidt R; Heitplatz B; Van Marck V; Nolte I; Pavenstädt H; Reuter S; Brand M; Di Marco GS
Kidney Int; 2019 May; 95(5):1091-1102. PubMed ID: 30824181
[TBL] [Abstract][Full Text] [Related]
9. Circulating Soluble Fms-like Tyrosine Kinase in Renal Diseases Other than Preeclampsia.
Wewers TM; Schulz A; Nolte I; Pavenstädt H; Brand M; Di Marco GS
J Am Soc Nephrol; 2021 Aug; 32(8):1853-1863. PubMed ID: 34155060
[TBL] [Abstract][Full Text] [Related]
10. AST-120, an Oral Carbon Absorbent, Protects against the Progression of Atherosclerosis in a Mouse Chronic Renal Failure Model by Preserving sFlt-1 Expression Levels.
Nakada Y; Onoue K; Nakano T; Ishihara S; Kumazawa T; Nakagawa H; Ueda T; Nishida T; Soeda T; Okayama S; Watanabe M; Kawakami R; Saito Y
Sci Rep; 2019 Oct; 9(1):15571. PubMed ID: 31666542
[TBL] [Abstract][Full Text] [Related]
11. Soluble fms-Like Tyrosine Kinase 1 as a Link Between Angiogenesis and Endothelial Dysfunction in Pediatric Patients With β-Thalassemia Intermedia.
Tantawy AAG; Adly AAM; Ismail EAR; Youssef OI; Ali ME
Clin Appl Thromb Hemost; 2017 Nov; 23(8):943-950. PubMed ID: 28301910
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum placental growth factor and soluble fms-like tyrosine kinase 1 as early predictors of preeclampsia.
Shokry M; Bedaiwy MA; Fathalla MM; Alsemary A; Elwakil S; Murphy A
Acta Obstet Gynecol Scand; 2010; 89(1):143-6. PubMed ID: 20021269
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction.
Onoue K; Uemura S; Takeda Y; Somekawa S; Iwama H; Nishida T; Morikawa Y; Nakagawa H; Tsutsumi T; Sung JH; Takemoto Y; Soeda T; Okayama S; Ishigami K; Kawata H; Horii M; Nakajima T; Saito Y
Am J Cardiol; 2009 Dec; 104(11):1478-83. PubMed ID: 19932778
[TBL] [Abstract][Full Text] [Related]
14. Soluble fms-like tyrosine kinase-1 and atherosclerosis in chronic kidney disease.
Luft FC
Kidney Int; 2014 Feb; 85(2):238-40. PubMed ID: 24487364
[TBL] [Abstract][Full Text] [Related]
15. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients.
Verlohren S; Herraiz I; Lapaire O; Schlembach D; Moertl M; Zeisler H; Calda P; Holzgreve W; Galindo A; Engels T; Denk B; Stepan H
Am J Obstet Gynecol; 2012 Jan; 206(1):58.e1-8. PubMed ID: 22000672
[TBL] [Abstract][Full Text] [Related]
16. Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1).
Youssry I; Makar S; Fawzy R; Wilson M; AbdAllah G; Fathy E; Sawires H
Pediatr Nephrol; 2015 Dec; 30(12):2163-8. PubMed ID: 26238275
[TBL] [Abstract][Full Text] [Related]
17. Soluble Fms-like tyrosine kinase 1 is a novel predictor of brain natriuretic peptide elevation.
Kameda R; Yamaoka-Tojo M; Makino A; Wakaume K; Nemoto S; Kitasato L; Shimohama T; Tojo T; Machida Y; Izumi T
Int Heart J; 2013; 54(3):133-9. PubMed ID: 23774235
[TBL] [Abstract][Full Text] [Related]
18. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia.
Verlohren S; Herraiz I; Lapaire O; Schlembach D; Zeisler H; Calda P; Sabria J; Markfeld-Erol F; Galindo A; Schoofs K; Denk B; Stepan H
Hypertension; 2014 Feb; 63(2):346-52. PubMed ID: 24166751
[TBL] [Abstract][Full Text] [Related]
19. sFlt-1 in Chronic Kidney Disease: Friend or Foe?
Matsui M; Onoue K; Saito Y
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430665
[TBL] [Abstract][Full Text] [Related]
20. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia.
Buhimschi CS; Norwitz ER; Funai E; Richman S; Guller S; Lockwood CJ; Buhimschi IA
Am J Obstet Gynecol; 2005 Mar; 192(3):734-41. PubMed ID: 15746665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
